Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

TAKE THese COURSes

FACULTY

Alan Menter, MD
Texas Dermatology Associates
Dallas, Texas, United States
IPC Founding President

Dr. Menter is Chairman of the Division of Dermatology and Director of the Dermatology Residency program for Baylor University Medical Center, and Clinical Professor of Dermatology at the University of Texas Southwestern Medical School, both in Dallas. After obtaining his medical degree from the University of Witwatersrand in Johannesburg, South Africa, Professor Menter completed his residency in dermatology at the University of Pretoria in South Africa and fellowships at Guy's Hospital in London and St. John's Hospital for Diseases of the Skin in London, as well as the University of Texas Southwestern Medical School. Dr. Menter is board-certified in dermatology. He is involved in multiple clinical, investigative and drug research studies, particularly those relating to psoriasis. In August 2004, he founded the International Psoriasis Council (IPC).

Last Updated: 1/2/2014 12:00:00 AM

 

Elise Kleyn, MRCP, MMedSci, PhD
University of Manchester
Manchester, England, Great Britain (UK)

Dr. Kleyn is a Clinical Senior Lecturer in Dermatology at The University of Manchester and Honorary Consultant Dermatologist at Salford Royal NHS Foundation Trust, Manchester. She received her MBChB degree from The University of Cape Town, South Africa and pursued her postgraduate training in the United Kingdom. She trained in dermatology on the North West Regional Dermatology Training Scheme. In 2008 she received her PhD degree from The University of Manchester and in 2010 she was awarded her MMedSci degree from the University of Liverpool. Dr. Kleyn is one of the five Consultant Dermatologists who lead the Manchester Psoriasis Service - a multidisciplinary clinic for patients with severe psoriasis - which was awarded Hospital Doctor Dermatology Team of the Year Award in 2002. She is also the Pharmacovigilance Lead for the British Association of Dermatologists Biologic Intervention Register (BADBIR). Her research has focused on the 'brain-skin' axis in health and disease (forming the basis of her PhD thesis), psoriasis and drug safety of biological therapies and their use in psoriasis. For her research relating to the brain-skin axis she has received a number of national awards. She is actively involved in medical education both in the clinical setting and as an Academic and Project Options supervisor.

Last Updated: 1/26/2018 12:00:00 AM


TERM OF APPROVAL

June 2018 through June 2019.

This website uses cookies. Please ensure your cookies are enabled. 
OK